Abstract
This report:
- Reviews global markets for prescription and over-the-counter therapeutic
drugs and forecasts sales through 2012.
- Analyzes epidemiological, technological, drug development, regulatory, and
competitive factors expected to influence drug sales and offers a qualitative
as well as quantitative picture of the world pharmaceutical market in 2012.
- Discusses epidemiology, treatment algorithms, and relevant major
manufacturers for each indication, accompanied by an analysis of current
sales, major trends and future sales within this indication. Indications
include cardiovascular disease, cancer, diabetes, depression and anxiety,
infectious diseases, and others. Drug classes selected for analysis include
cholesterol and triglyceride reducers, anti-ulcerants, antidepressants,
antirheumatic non-steroidals, antipsychotics, calcium antagonists,
erythropoeitins, ACE inhibitors, selected anti-cancer therapeutics, and others.
- Covers novel therapeutic monoclonal antibodies, therapeutic vaccines, stem
cell products, and engineered therapeutic foods. The report discusses both
expected and alternative scenarios for selected drug classes.
- Includes market shares, competitive analysis, regulatory considerations,
patent analyses, and complete company profiles.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This study examines world pharmaceutical markets and provides pertinent
information about sales and production of pharmaceutical products, as well as
information about national healthcare systems and drug pricing policies. The
report covers 24 countries in detail and provides links to relevant
information. There are also profiles of larger pharmaceutical and
biotechnology companies, complete with revenue histories.
Trends in government policies concerning drug pricing and reimbursement are
examined. The report also makes predictions about countries whose
pharmaceutical market growth is likely to grow radically in the next 5 years.
REASONS FOR DOING THE STUDY
Although the pharmaceutical industry remains one of the most profitable and
stable industries in the world, several variables are forcing fundamental
changes in its structure. They are:
- Increasing government-imposed price reductions in prices
- An increasing role of generic substitutes (especially in Europe)
- The emergence of bio-pharmaceuticals and the bio-omics revolution
- Increasing buyer power of third-party payers, government buyers, and
health maintenance organizations
- Increased health awareness among patients and government buyers
- Changing suppliers-enhanced outsourcing, in-licensing, contract research,
and manufacturing activities.
- Additionally, changing world demographics are influencing the
pharmaceutical industry. They include population aging, declining research and
development (R&D) productivity, and the General Agreements on Tariffs and
Trade (GATT) and Trade Related Intellectual Property Rights (TRIPS).
AUDIENCE FOR THE REPORT
This report is directed at decision-makers in each industry segment, as well
as at individuals and organizations considering investing in drug discovery or
drug discovery technology. These people include, but are not limited to the
following:
- Business development professionals
- Venture capitalists
- Merger and acquisition executives
- Market and product management professionals
- Chief scientists and technical officers
- Equipment manufacturers
- Reagent suppliers
SCOPE AND FORMAT
The scope of this study encompasses the major sectors of the world
pharmaceutical industry and major geographical markets. BCC Research has
analyzed the forces affecting the world pharmaceutical markets, determined
their impact on the market demand and growth, and also presented the growth
forecast over the next 5 years. Key forces include the increasing role of
substitutes (generic pharmaceuticals), threat of new entrants
(biopharmaceuticals), increasing role of buyers (governments, insurance,
etc.), and changing suppliers.
BCC Research has provided the comprehensive analyses of the industry on the
worldwide basis and also provided the detailed profiles for 25 leading
pharmaceutical markets across the globe. For each of the geographical markets,
we have presented the sector information, pharmaceutical distribution and
pricing, and reimbursement and regulations. In a nutshell, the report provides
the reader with a one-stop analysis of the worldwide pharmaceutical industry.
METHODOLOGY AND INFORMATION SOURCES
Market data and other information used in this report was gathered from
interviews with individuals in the industry, as well as a thorough review of
technology and markets gathered from secondary sources. These sources include
company annual, 10K and 10Q reports, company literature, trade literature,
trade associations, and online sources. Note that the author of this report is
herself involved in the development of a compound for amyotrophic lateral
sclerosis.
Projections were based on current and historical levels of funding and
revenues, potential end users, likely unit prices and rates of consumption.
Final projections are based on the analysis of information from primary and
secondary sources. All currency conversions were made based on the average
value of the dollar during the last month of the year in question. In some
cases, data is provided in the original currency for readers wishing to make
their own comparisons. An online currency converter was used for this
purpose.[1] All forecasts are presented in year 2008 constant dollars.
|
Related Report
|
View Cart
